Van professionele vertalers, bedrijven, webpagina's en gratis beschikbare vertaalbronnen.
when decarboxylation of levodopa is reduced with the co-administration of a ddc inhibitor, a lower dose of levodopa can be used and the incidence of adverse reactions such as nausea is reduced.
kui levodopa dekarboksüleerimist vähendada ddc inhibiitori koosmanustamisega, saab kasutada väiksemat levodopa annust ja sellega vähendada kõrvaltoimete (iiveldus) esinemissagedust.
the addition of carbidopa to levodopa reduces the peripheral effects (nausea, vomiting) due to decarboxylation of levodopa; however, carbidopa does not decrease the adverse reactions due to the central effects of levodopa.
karbidopa lisamine levodopale vähendab perifeerseid toimeid (iiveldus, oksendamine), mille põhjustab levodopa dekarboksüleerumine; karbidopa ei vähenda aga kõrvaltoimeid, mis tulenevad levodopa tsentraalsetest toimetest.